BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4408076)

  • 1. [New aspects in the therapy of cerebrovascular diseases. Hemodynamic studies with a combination of coumarin-rutin-theophylline].
    Klein K
    Arzneimittelforschung; 1974 Jul; 24(7):1066-9. PubMed ID: 4408076
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hemodynamic principles of therapygin cerebrovascular diseases].
    Klein K
    Med Klin; 1973 May; 68(18):572-9. PubMed ID: 4576604
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical ophthalmodynamographic results of the treatment of cerebral circulation disorders with O-(beta-hydroxyethyl)-rutoside].
    Tzavellas O
    Arzneimittelforschung; 1970 Sep; 20(9):1187-90. PubMed ID: 5536794
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with the preparation Seniosan].
    Pernhaupt G
    Med Monatsschr; 1969 Oct; 23(10):461-4. PubMed ID: 4242114
    [No Abstract]   [Full Text] [Related]  

  • 6. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
    Ishchenko MM; Shkrobot SI
    Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age].
    Giovanardi F; Bisceglia G
    Clin Ter; 1971 Aug; 58(3):243-53. PubMed ID: 5135003
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K
    Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ophthalmodynamography as the testing method in therapeutic agent tests].
    Zurwehme D; Hahn E
    Med Klin; 1968 Mar; 63(13):496-9. PubMed ID: 5727262
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of venous and arterious circulation disorders using Melilotus].
    Mahr H
    Med Monatsschr; 1971 Jul; 25(7):334-6. PubMed ID: 5563917
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of a preparation combining Melilot and hydrosoluble rutin on trophic disorders of the lower limb of vascular origin].
    Desmons F; Simons M
    Lille Med; 1975 Jan; 20(1):76-8. PubMed ID: 1134177
    [No Abstract]   [Full Text] [Related]  

  • 13. [Indications for Ustimon and Instenon therapy in cerebrovascular diseases].
    Eichhorn O
    Wien Klin Wochenschr; 1967 Jan; 79(4):67-71. PubMed ID: 5340281
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
    Khadzhiev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of theophyllinyl 7- -n propane sulfonate of papaverine in rehabilitation and functional readaptation].
    Blanc A; Perset P
    Therapeutique; 1971 Apr; 47(4):391-3. PubMed ID: 5564052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical use of a new vasoactive drug : nicergoline].
    Mellini M
    Minerva Med; 1973 May; 64(34):1844-53. PubMed ID: 4719381
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of dihydroergotamine in patients with orthostatic dystonia].
    Rieger P; Slany E
    Wien Med Wochenschr; 1970 May; 120(18):338-44. PubMed ID: 5490869
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Geriatric contribution on the treatment of cerebral circulatory disorders].
    Berger E; Schmidt K
    Wien Klin Wochenschr; 1969 Nov; 81(46):836-8. PubMed ID: 5380789
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical experiences with gerontotherapeutic agent Wallerox (GN 468)].
    Voegt H; Haid E
    Med Klin; 1970 Nov; 65(46):2031-5. PubMed ID: 5000077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.